Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON (JNJ)

209
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

08/21/2012 | 06:13pm US/Eastern
Recommend:
0
   By Ben Fox Rubin 
 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Recommend :
0
React to this article
Latest news on JOHNSON & JOHNSON
1d agoDJWANTED : Biotech Startups in New York City
1d agoDJJOHNSON & JOHNSON : Press Release : FDA expands approved use of Imbruvica for ch..
5d ago JOHNSON & JOHNSON : Untraceable implants adding to woes
5d ago Activist Elliott Management sets its sights on IPG
6d ago JOHNSON & JOHNSON : New Findings on Dermatology from Johnson & Johnson Summarize..
6d ago JOHNSON & JOHNSON : Announces Quarterly Dividend for Third Quarter 2014
6d ago JOHNSON & JOHNSON : Announces $5 Billion Share Repurchase Program
6d ago JOHNSON & JOHNSON : J&J buying back $5 billion worth of its shares
07/22DJJOHNSON & JOHNSON : Study Finds New Cancer Risk from Hysterectomy Device
07/22DJU.S. HOT STOCKS : Hot Stocks to Watch
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
Johnson _ Johnson : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF